Impact of Kawasaki disease in the pediatric population.
PDF (Español (España))
HTML (Español (España))
AUDIO (Español (España))
صندلی اداری سرور مجازی ایران Decentralized Exchange

How to Cite

1.
Molina Jiménez VN, Barquero Orias DE, Peña Miranda M. Impact of Kawasaki disease in the pediatric population. Rev.méd.sinerg. [Internet]. 2019Jan.1 [cited 2024Jul.3];4(1):35 - 45. Available from: https://revistamedicasinergia.com/index.php/rms/article/view/201

Abstract

Kawasaki disease it’s an acute vasculitis of unknown etiology that is characterized by an immune response in patients that are genetically predispose to develop the disease. It affects children below the age of 5 predominantly. The diagnosis is made based on the clinical characteristics, laboratory data and demonstration of coronary aneurisms with an echocardiography. This disease is the primary cause of acquired cardiac disease in children, since the vasculitis affects medium sized vessels, primarily the coronary arteries, which provoke the formation of coronary aneurisms that can trigger a thrombosis. It is essential to make an early diagnosis, so that the treatment can be established to prevent the fatal consequences of the disease product of the formation of aneurisms, which develop in 25% of patients that do no receive and adequate treatment.

https://doi.org/10.31434/rms.v4i1.201

Keywords

Mucocutaneous lymph node syndrome. vasculitis. fever. exanthema. aneurysm.
PDF (Español (España))
HTML (Español (España))
AUDIO (Español (España))

References

1. Newburger J, Takahashi M, Burns J. Kawasaki Disease. Journal of the American College of Cardiology. 2016; 67(14): 1738-1749. https://doi.org/10.1016/j.jacc.2015.12.073

2. Gámez L, Yamazaki M. Enfermedad de Kawasaki: un vistazo al cincuenteno. Revista Investigación Médica Sur de México. 2015; 22(4): 169-181. Disponible en: https://www.medigraphic.com/pdfs/medsur/ms-2015/ms154c.pdf

3. Matiz Mejía S, Ariza Correa C, Salinas Suárez C, Huertas Quiñones M, Sanguino Lobo R. Enfermedad de Kawasaki. Revista Colombiana de Cardiología. 2017; 24(3): 307.e1-307.e6. https://doi.org/10.1016/j.rccar.2016.05.011

4. Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Archives of Disease in Childhood. 2015; 100(11): 1084-1088. https://doi.org/10.1136/archdischild-2014-307536

5. Kim K, Kim D. Recent Advances in Kawasaki Disease. Yonsei Medical Journal. 2016; 57(1): 15-21. https://doi.org/10.3349/ymj.2016.57.1.15

6. McCrindle B, Rowley A, Newburger J, Burns J, Bolger A, Gewitz M et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017; 135(17): e927-e999. https://doi.org/10.1161/CIR.0000000000000484

7. Gil G, Nieto N, León A, Hernandez Z. Enfermedad de Kawasaki. Revista Hospital Juárez de México. 2018; 85(3): 154-158. Disponible en: https://www.medigraphic.com/pdfs/juarez/ju-2018/ju183f.pdf

8. Chen P, Chi H, Huang F, Peng C, Chen M, Chiu N. Clinical manifestations of Kawasaki disease shock syndrome: A case-control study. Journal of Microbiology, Immunology and Infection. 2015; 48(1): 43-50. https://doi.org/10.1016/j.jmii.2013.06.005

9. Turnier J, Anderson M, Heizer H, Jone P, Glode M, Dominguez S. Concurrent Respiratory Viruses and Kawasaki Disease. PEDIATRICS. 2015; 136(3): e609-e614. https://doi.org/10.1542/peds.2015-0950

10. Singh S, Agarwal S, Bhattad S, Gupta A, Suri D, Rawat A et al. Kawasaki disease in infants below 6 months: a clinical conundrum?. International Journal of Rheumatic Diseases. 2016; 19(9): 924-928. https://doi.org/10.1111/1756-185X.12854

11. Li W, Zhang L, Huang P, Zhang Z. Clinical features and mid-term follow-up in infants younger than 3 months with Kawasaki disease in a Chinese population. Journal of Paediatrics and Child Health. 2018; e14233. https://doi.org/10.1111/jpc.14233

12. Kuwabara M, Yashiro M, Kotani K, Tsuboi S, Ae R, Nakamura Y et al. Cardiac Lesions and Initial Laboratory Data in Kawasaki Disease: a Nationwide Survey in Japan. Journal of Epidemiology. 2015; 25(3) :189-193. https://doi.org/10.2188/jea.JE20140128

13. Barrios Tascón A, Centeno Malfaz F, Rojo Sombrero H, Fernández-Cooke E, Sánchez-Manubens J, Pérez-Lescure Picarzo J. Consenso nacional sobre diagnóstico, tratamiento y seguimiento cardiológico de la enfermedad de Kawasaki. Anales de Pediatría. 2018; 89(3): 188.e1-188.e22. https://doi.org/10.1016/j.anpedi.2018.04.003

14. Owens S, Agyeman P, Whyte M, Crossland D, Flood T, Abinun M. Aggressive anti-inflammatory treatment for refractory Kawasaki disease. Journal of Infection. 2017; 74(1): 91-95. https://doi.org/10.1016/j.jinf.2016.08.015

15. Sánchez Andrés A, Salvador Mercader I, Seller Moya J, Carrasco Moreno J. Giant coronary aneurysms in infants with Kawasaki disease. Anales de Pediatría. 2017; 87(2): 65-72. https://doi.org/10.1016/j.anpede.2016.07.005

16. Kourtidou S, Slee A, Bruce M, Wren H, Mangione-Smith R, Portman M. Kawasaki Disease Substantially Impacts Health-Related Quality of Life. The Journal of Pediatrics. 2018; 193: 155-163.e5. https://doi.org/10.1016/j.jpeds.2017.09.070

Downloads

Download data is not yet available.
فروشگاه اینترنتی صندلی اداری جوراب افزایش قد ژل افزایش قد صندلی اداری vpn for android